M Maroñas Martín1, J Rubio Briones, L Arribas Alpuente
1Servicio de Oncología Radioterápica, Fundación Instituto Valenciano de Oncología, Valencia.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Patients receiving abdominopelvic radiotherapy face an increased risk of developing muscle-infiltrating transitional cell carcinoma (TCC). Persistent urinary symptoms warrant thorough investigation for TCC in this high-risk group.
Area of Science:
Background:
Observation:
Findings:
Implications: